Book contents
- Frontmatter
- Contents
- List of contributors
- Acknowledgements
- 1 Introduction
- Section I Information problems
- Section II End of life care
- Section III Pregnant women and children
- Section IV Genetics and biotechnology
- Section V Research ethics
- Section VI Health systems and institutions
- Section VII Using clinical ethics to make an impact in healthcare
- Section VIII Global health ethics
- Introduction
- 43 Global health ethics and cross-cultural considerations in bioethics
- 44 Physician participation in torture
- 45 Access to medicines and the role of corporate social responsibility: the need to craft a global pharmaceutical system with integrity
- 46 Global health and non-ideal justice
- Section IX Religious and cultural perspectives in bioethics
- Section X Specialty bioethics
- Index
- References
43 - Global health ethics and cross-cultural considerations in bioethics
Published online by Cambridge University Press: 30 October 2009
- Frontmatter
- Contents
- List of contributors
- Acknowledgements
- 1 Introduction
- Section I Information problems
- Section II End of life care
- Section III Pregnant women and children
- Section IV Genetics and biotechnology
- Section V Research ethics
- Section VI Health systems and institutions
- Section VII Using clinical ethics to make an impact in healthcare
- Section VIII Global health ethics
- Introduction
- 43 Global health ethics and cross-cultural considerations in bioethics
- 44 Physician participation in torture
- 45 Access to medicines and the role of corporate social responsibility: the need to craft a global pharmaceutical system with integrity
- 46 Global health and non-ideal justice
- Section IX Religious and cultural perspectives in bioethics
- Section X Specialty bioethics
- Index
- References
Summary
The AIDS Clinical Trials Group Study 076 (ACTG 076) made an important contribution to prevention of HIV infection when it established that mother-to-child transmission of HIV (MTCT) in the USA and France could be significantly reduced by giving antiretroviral drugs to pregnant women orally for 8 weeks or more prior to childbirth (median 14 weeks) and intravenously during labor, as well as to the newborn child for 6 weeks in the absence of breast feeding (Connor et al., 1994). A major controversy developed when in subsequent studies of MTCT in developing countries shorter courses of treatment were compared with placebo. Although there is no reason to believe that the ACTG 076 regimen would not work in developing countries if it could be applied, placebo studies were undertaken instead. The rationale was that use of the ACTG 076 regimen was precluded in developing countries, not only by its extremely high cost but, more relevantly, because women do not present early enough in pregnancy to receive this prolonged and intensive regimen. In addition they are anemic and malnourished, unable to stop breast feeding, and have difficulty providing treatment to a child for a six-week period (Varmus and Satcher, 1997). Consequently, cheaper and more easily applied preventive methods needed to be studied to enable rapid application of this preventive method to save many lives in developing countries.
What is global health ethics?
Global health ethics is a suggested means through which to promote widely values that include meaningful respect for human life, human rights, equity, freedom, democracy, environmental sustainability, and solidarity (Benatar et al., 2003).
- Type
- Chapter
- Information
- The Cambridge Textbook of Bioethics , pp. 341 - 349Publisher: Cambridge University PressPrint publication year: 2008
References
- 2
- Cited by